Ikarovec

Ikarovec is the operator of a gene therapy company aimed at treating common eye diseases. The company targets multiple disease pathways to help address diabetic macular edema, dry age-related macular degeneration, neovascular (wet) age-related macular degeneration, and ocular hypertension, enabling patients to receive the treatments needed to restore vision and prevent blindness.